Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-11 Purchase | 2022-11-14 4:13 pm | GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer | 25,000 | $1.29 | $32,250 | 25,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-12 Option Award | 2024-01-17 4:05 pm | N/A 2034-01-11 | GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer | 695,000 | $0 | 695,000 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-20 4:04 pm | N/A 2033-01-18 | GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer | 651,200 | $0 | 651,200 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 8:58 pm | N/A 2032-01-20 | GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer | 423,500 | $0 | 423,500 (Direct) | View |
Ownership | 2021-08-10 4:16 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer | 0 | $0 | 1,647,600 (Direct) | View |
| 2020-04-16 Option Award | 2020-04-20 4:41 pm | N/A 2027-04-16 | IMMUNOMEDICS INC | IMMU | Semerjian Harout President and CEO | 302,677 | $0 | 302,677 (Direct) | View |